• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jvirolPermissionsJournals.ASM.orgJournalJV ArticleJournal InfoAuthorsReviewers
J Virol. Apr 1992; 66(4): 1835–1840.
PMCID: PMC288969

Protective immune response against foot-and-mouth disease.

Abstract

The causative agents of foot-and-mouth disease (FMD) are small icosahedral viruses of the Aphthovirus group within the Picornaviridae family. There is no evidence that these viruses infect cells of the immune system or otherwise interfere detrimentally with their function; additionally, it has not been possible to relate cytotoxicity reactions against virus-infected cells to the efficacy of the immune response against FMD virus infection. In contrast, there is a close association between FMD virus antibody and the protective immune response (10, 14, 15, 20, 24, 25, 29-32). Induction of this antibody is dependent on the structure of the viral antigenic sites (7-9, 11, 18) and on the concomitant presence of Th-lymphocyte epitopes (4, 5, 7, 8), although a Th-lymphocyte-independent response has been reported (2). Recent work by Piatti et al. (26) showed that the immune response induced by FMD virus was only Th-lymphocyte dependent when low doses of antigen were used. This latter work was performed in mice, and it is not certain that a similar situation would be found in cattle. As for the major effector immune defense, this relies on the interaction between antibody-virus complexes and the phagocytic cells of the reticuloendothelial system (17, 19).

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baxt B, Morgan DO, Robertson BH, Timpone CA. Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment. J Virol. 1984 Aug;51(2):298–305. [PMC free article] [PubMed]
  • Borca MV, Fernández FM, Sadir AM, Braun M, Schudel AA. Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus-independent primary and secondary reaction. Immunology. 1986 Oct;59(2):261–267. [PMC free article] [PubMed]
  • Collen T, Dimarchi R, Doel TR. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol. 1991 Jan 15;146(2):749–755. [PubMed]
  • Collen T, Pullen L, Doel TR. T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol. 1989 Feb;70(Pt 2):395–403. [PubMed]
  • Duchesne M, Cartwright T, Crespo A, Boucher F, Fallourd A. Localization of a neutralization epitope of foot-and-mouth disease virus using neutralizing monoclonal antibodies. J Gen Virol. 1984 Sep;65(Pt 9):1559–1566. [PubMed]
  • Francis MJ, Hastings GZ, Clarke BE, Brown AL, Beddell CR, Rowlands DJ, Brown F. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology. 1990 Feb;69(2):171–176. [PMC free article] [PubMed]
  • Francis MJ, Hastings GZ, Syred AD, McGinn B, Brown F, Rowlands DJ. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature. 1987 Nov 12;330(6144):168–170. [PubMed]
  • Flynn JN, Harkiss GD, Doel T, DiMarchi R. Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies. Immunology. 1990 Jan;69(1):1–7. [PMC free article] [PubMed]
  • Hamblin C, Barnett IT, Crowther JR. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application. J Immunol Methods. 1986 Oct 23;93(1):123–129. [PubMed]
  • Haresnape JM, King AM, McCahon D. Location of an immunizing determinant within polypeptide VP1 of type O aphthovirus. J Gen Virol. 1983 Nov;64(Pt 11):2357–2365. [PubMed]
  • McCullough KC, Crowther JR, Butcher RN. A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens. J Virol Methods. 1985 Aug;11(4):329–338. [PubMed]
  • McCullough KC, Crowther JR, Butcher RN, Carpenter WC, Brocchi E, Capucci L, De Simone F. Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology. 1986 Jul;58(3):421–428. [PMC free article] [PubMed]
  • McCullough KC, Crowther JR, Carpenter WC, Brocchi E, Capucci L, De Simone F, Xie Q, McCahon D. Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology. 1987 Apr;157(2):516–525. [PubMed]
  • McCullough KC, Parkinson D, Crowther JR. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology. 1988 Oct;65(2):187–191. [PMC free article] [PubMed]
  • McCullough KC, Smale CJ, Carpenter WC, Crowther JR, Brocchi E, De Simone F. Conformational alteration in foot-and-mouth disease virus virion capsid structure after complexing with monospecific antibody. Immunology. 1987 Jan;60(1):75–82. [PMC free article] [PubMed]
  • Meloen RH, Briaire J, Woortmeyer RJ, van Zaane D. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI. J Gen Virol. 1983 May;64(Pt 5):1193–1198. [PubMed]
  • Mulcahy G, Gale C, Robertson P, Iyisan S, DiMarchi RD, Doel TR. Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine. 1990 Jun;8(3):249–256. [PubMed]
  • Müller HK, Villinger F, Griot C, Ackermann M, Bruckner L, Kihm U. Untersuchungen zur Wirksamkeit der MKS-Impfstoffe in der Schweiz I. Schutzversuche und Herdenimmunität. Schweiz Arch Tierheilkd. 1989;131(7):379–386. [PubMed]
  • Piatti PG, Berinstein A, Lopez OJ, Borca MV, Fernandez F, Schudel AA, Sadir AM. Comparison of the immune response elicited by infectious and inactivated foot-and-mouth disease virus in mice. J Gen Virol. 1991 Jul;72(Pt 7):1691–1694. [PubMed]
  • Robertson BH, Morgan DO, Moore DM. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12. Virus Res. 1984 Sep;1(6):489–500. [PubMed]
  • SKINNER HH. Propagation of strains of foot-and-mouth disease virus in unweaned white mice. Proc R Soc Med. 1951 Dec;44(12):1041–1044. [PMC free article] [PubMed]
  • van Maanen C. A complex-trapping-blocking (CTB) ELISA, using monoclonal antibodies and detecting specifically antibodies directed against foot-and-mouth disease types A, O and C. II. Application. Vet Microbiol. 1990 Aug;24(2):179–191. [PubMed]
  • Van Maanen C, Terpstra C. Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J Immunol Methods. 1989 Nov 13;124(1):111–119. [PubMed]
  • Xie QC, McCahon D, Crowther JR, Belsham GJ, McCullough KC. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol. 1987 Jun;68(Pt 6):1637–1647. [PubMed]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

Formats: